In this 17-minute video, I explain my approach to exosomes. We discuss the objective measurements of aging that we use. In addition, we discuss the risks of placebo, nocebo, and unknown unknowns. The most important criterion is are you willing to take a chance on a logical intervention in the context of a patient-physician relationship?
You should always focus on the quality of your relationships rather than the quantity of them
Taking telomerase activators appears to have not increased my objective telomere length as I’ve become older
Peter Voss explains what adaptive, artificial GENERAL intelligence is. He explains the kinds of cognitive feelings these machines need. Finally, he and Dr. Park explore whether machine intelligence can and should be programmed to value and defend itself.
I am feeling very grateful all the people I speak to and correspond with every day who convey their positive benefits while taking TA-65 or Recharge.